Sirona Dental Systems (XRAY) - Long-Term Liabilities to Capital

Corporate emblem and logo of Sirona Dental Systems (XRAY)

This market valuation chart for DENTSPLY SIRONA Inc. (XRAY) reflects the asset's dynamics, with a metric of 1.66. The business is striving for dominance in the digital dental equipment segment by integrating 3D printing and specialized software into a single ecosystem. Current management is successfully implementing strict reporting oversight and increasing profitability, while a flawless brand image confirms its status as the quality benchmark among global clinics.

Dentsply - XRAY Long-Term Debt to Capital (period 07/04/2022 - 11/01/2026)

Comprehensive metric breakdowns and analytics for DENTSPLY SIRONA Inc. (XRAY)

- stock value and consensus price forecast:
Stock Quotes Dentsply Sirona Inc|XRAY - Analyst Consensus Forecast
- market capitalization indicators:
Market Value DENTSPLY SIRONA Inc.|XRAY - Enterprise Value
- book value of equity indicators:
Equity per Share Dentsply Sirona|XRAY - Book Capitalization|Market Capitalization to Book Value dentsplysirona.com|XRAY - Company Total Assets
- debt and solvency information:
Total Debt to Equity Ratio DENTSPLY SIRONA Inc.|XRAY - Long-Term Debt to Capital|Short-Term Debt to Capital dentsplysirona.com|XRAY - Company Debts|Debt to Book Capitalization Ratio DENTSPLY SIRONA Inc.|XRAY - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Dentsply Sirona|Interim Coverage Ratio dentsplysirona.com
- financial results and valuation multiples details:
XRAY - Company Net Income
Comprehensive company analysis:Dentsply Sirona Inc
Signature product of DENTSPLY SIRONA Inc.

To identify the sector's fundamental leaders, the analyst evaluates the ratio of liabilities with a maturity of over one year to equity, which determines the stability of the financial structure. This long-term debt leverage demonstrates how DENTSPLY SIRONA Inc. (XRAY) balances borrowed funds to finance high-tech R&D projects in digital dentistry and AI without creating excessive risks for shareholders.

Competing companies

Long-Term Debt to Equity Ratio Intuitive Surgical, Inc. (ISRG)|Long-Term Debt to Capital DHR|BDX - Long-Term Liabilities to Capital|Long-Term Debt to Capital STE (STERIS plc)|WST: Long-Term Debt to Capital Ratio|Baxter - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Masimo Corp MASI|STVN: Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Teleflex Corp|MMSI (Merit Medical Systems) - Long-Term Debt to Capital|Long-Term Debt to Capital envistaco.com|Long-Term Debt to Equity ICU Medical (ICUI)|Long-Term Debt to Equity LMAT (LeMaitre Vascular Inc)|AtriCure Corp - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient STAA|ChromaDex Corp. - Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital zimvie.com ZIMV|AngioDynamics (ANGO) - Long-Term Debt to Equity|Long-Term Debt to Capital Ratio CERS|Long-Term Debt to Equity Alpha Teknova Inc|Monogram Orthopedics Inc. (MGRM) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Ratio STSS (Sharps Technology, Inc.)|Long-Term Loans to Capital Ratio INFU|Long-Term Debt to Equity Utah Medical Products, Inc. UTMD|Long-Term Debt to Capital Coefficient KRMD|NYXH: Long-Term Debt to Equity Ratio|MBOT - Long-Term Debt to Capital|Pro-Dex, Inc. (PDEX) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio zentek.com|ELUT (Elutia) - Long-Term Debt to Capital|Long-Term Liabilities to Capital Milestone Scientific Inc MLSS|Long-Term Debt to Equity NEXGEL, Inc (NXGL)|retractable.com - Long-Term Debt to Capital Ratio|Harvard Bioscience, Inc. - Long-Term Debt to Equity Ratio|Long-Term Loans to Capital Ratio FEMY (femasys.com)|MHUA - Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital Predictive Oncology POAI|CJMB: Long-Term Debt to Capital|Long-Term Debt to Capital Ratio ATRI|NURO (NeuroMetrix, Inc.) - Long-Term Debt to Capital